Download Chapter_008

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Monoclonal antibody wikipedia , lookup

Infection control wikipedia , lookup

Molecular mimicry wikipedia , lookup

Cancer immunotherapy wikipedia , lookup

Psychoneuroimmunology wikipedia , lookup

Polyclonal B cell response wikipedia , lookup

Immunomics wikipedia , lookup

Immunosuppressive drug wikipedia , lookup

Transcript
Chapter 8
Alterations in Immunity and
Inflammation
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Hypersensitivity

Altered immunologic response to an antigen;
results in disease/damage to host

Allergy
• Deleterious effects of hypersensitivity to environmental
(exogenous) antigens


Autoimmunity
• Disturbance in immunologic tolerance of self-antigens
Alloimmunity
• Immune reaction to tissues of another individual
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
2
Hypersensitivity

Characterized by the immune mechanism

Type I
• IgE mediated
 Type II
• Tissue-specific reactions
 Type III
• Immune complex mediated
 Type IV
• Cell mediated
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
3
Hypersensitivity



Immediate hypersensitivity reactions
Anaphylaxis
Delayed hypersensitivity reactions
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
4
Type I Hypersensitivity




IgE mediated
Against environmental antigens (allergens)
IgE binds to Fc receptors on surface of mast
cells (cytotropic antibody)
Histamine release


H1 and H2 receptors
Antihistamines
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
5
Type I
Mast Cell
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
6
Type I Hypersensitivity

Manifestations








Itching
Urticaria
Conjunctivitis
Rhinitis
Hypotension
Bronchospasm
Dysrhythmias
GI cramps and malabsorption
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
7
Clinical Symptoms of IgE Type I
Reactions
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
8
Anaphylaxis



Severity depends on level of sensitization
Can be very small dose (ordinary skin testing)
Within minutes after exposure:







Itching
Hives
Skin erythema
Contraction of respiratory bronchioles
Laryngeal edema results in hoarseness
Vomiting, abdominal cramps, diarrhea
Laryngeal obstruction
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
9
Type I Hypersensitivity


Genetic predisposition
Tests




Food challenges
Skin tests
Laboratory tests
Desensitization

IgG-blocking antibodies
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
10
Type II Hypersensitivity

Tissue specific


Specific cell or tissue (tissue-specific antigens) is
the target of an immune response
Five mechanisms





Cell is destroyed by antibodies and complement
Cell destruction through phagocytosis
Soluble antigen may enter the circulation and
deposit on tissues
Antibody-dependent cell-mediated cytotoxicity
Causes target cell malfunction
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
11
Phagocytosis
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
12
Neutrophil-Mediated Damage
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
13
Antibody-Dependent Cell-Mediated
Cytotoxicity
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
14
Induced Cell Malfunction
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
15
Type III Hypersensitivity




Immune complex mediated
Antigen-antibody complexes formed in the
circulation and later deposited in vessel walls
or extravascular tissues
Not organ specific
Immune complex clearance



Large—macrophages
Small—renal clearance
Intermediate—deposit in tissues
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
16
Type III Hypersensitivity
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
17
Examples of Immune Complex–
Mediated Diseases: Type III





Systemic lupus erythematosus
Vasculitis
Poststreptococcal glomerulonephritis
Acute glomerulonephritis
Reactive arthritis
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
18
Type IV Hypersensitivity

Mediated by T lymphocytes



Destruction of the tissue usually caused by direct
killing by toxins from Tc cells
Th1 cells produce cytokines that recruit phagocytes,
especially macrophages
Examples

Acute graft rejection, skin test for TB, contact allergic
reactions, and some autoimmune diseases
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
19
Type IV Hypersensitivity
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
20
Type IV Hypersensitivity
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
21
Antigenic Targets of
Hypersensitivity Reactions

Allergy


Autoimmunity


Environmental Ags
Self Ags, with damage to host tissues
Alloimmunity

Against foreign tissue Ags
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
22
Allergy

Environmental antigens that cause atypical
immunologic responses in genetically
predisposed individuals



Pollens, molds, fungi, foods, animals, etc.
Allergen contained within a particle too large to
be phagocytosed or is protected by a
nonallergenic coat
Original insult is apparent
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
23
Autoimmunity

Breakdown of tolerance


Sequestered antigen


Self-antigens not normally seen by the immune
system
Infectious disease


Body recognizes self-antigens as foreign
Molecular mimicry
Neoantigen

Haptens become immunogenic when they bind to
host proteins
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
24
Autoimmunity

Forbidden clone


Ineffective peripheral tolerance



During differentiation, lymphocytes produce
receptors that react with self-antigens
Defects in regulatory cells
Original insult
Genetic factors
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
25
Autoimmune Examples

Systemic lupus erythematosus (SLE)


Chronic multisystem inflammatory disease
Autoantibodies against:
• Nucleic acids, erythrocytes, coagulation proteins,
phospholipids, lymphocytes, platelets, etc.


Deposition of circulating immune complexes
containing antibody against host DNA
More common in females
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
26
Systemic Lupus Erythematosus

Clinical manifestations





Arthralgias or arthritis (90% of individuals)
Vasculitis and rash (70%–80%)
Renal disease (40%–50%)
Hematologic changes (50%)
Cardiovascular disease (30%–50%)
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
27
Systemic Lupus Erythematosus


Eleven common findings
Serial or simultaneous presence of at least
four indicates SLE

Facial (malar) rash, discoid rash, photosensitivity,
oral or nasopharyngeal ulcers, nonerosive
arthritis, serositis, renal disorders, neurologic
disorders, hematologic disorders, immunologic
disorders, and presence of antinuclear antibodies
(ANAs)
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
28
Alloimmunity

Immune system reacts with antigens on the
tissue of other genetically dissimilar members
of the same species

Transient neonatal alloimmunity
• Fetus expresses parental antigens not found in the
mother

Transplant rejection and transfusion reactions
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
29
Graft Rejection

Transplant rejection classified according to time



Hyperacute
• Immediate and rare
• Preexisting antibody to the antigens of the graft
Acute
• Cell-mediated response against unmatched HLA antigens
Chronic
• Months or years
• Inflammatory damage to endothelial cells of vessels due to
a weak cell-mediated reaction against minor HLA antigens
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
30
Transfusion Reactions


Antibodies against blood group antigens
ABO system

Two major carbohydrate antigens
• A and B (codominant)
• Individuals have naturally occurring antibodies to the A
•
•
•
•
and B antigens they lack
Anti-A and anti-B antibody production is induced by
similar antigens on naturally occurring bacteria in the
intestinal tract
Antibodies are usually of the IgM class
O blood type (universal donor)
AB blood type (universal recipient)
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
31
ABO Incompatibility:
Alloimmune Reaction
Blood
type
Ag
Ab
Incompatible with
blood type
A
A
Anti-B
B, AB
B
B
Anti-A
A, AB
AB
Universal
recipient
A+B
None
None
O
Universal
donor
None
Anti-A and Anti-B
A, B, AB
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
32
Immunodeficiencies

Result of impaired function of T cells, B cells,
phagocytes and/or complement




Primary (genetic)
Secondary (acquired)
Hallmark is recurrent infections often with
opportunistic organisms
Type of infection can lead to diagnosis of type of
deficiency
• Gonorrhea suggests complement deficiency
• Viral infections suggest T cell deficiency
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
33
Immunodeficiencies

Clinical presentation




Development of unusual or recurrent, severe
infections
T cell deficiencies
• Viral, fungal, yeast, and atypical microorganisms
B cell and phagocyte deficiencies
• Microorganisms requiring opsonization
Complement deficiencies
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
34
Immunodeficiencies

Primary (congenital) immunodeficiency


Genetic anomaly
Secondary (acquired) immunodeficiency


Caused by another illness
More common
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
35
Primary Immunodeficiencies


Most are the result of a single gene defect
Five groups





B lymphocyte deficiencies
T lymphocyte deficiencies
Combined T and B cell deficiencies
Complement defects
Phagocyte defects
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
36
B Lymphocyte Deficiencies

Hypogammaglobulinemia or
agammaglobulinemia

Bruton agammaglobulinemia
 Autosomal agammaglobulinemia
 X-linked hyper-IgM syndrome
 IgG subclass deficiency
 Selective IgA deficiency
 Common variable immunodeficiency
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
37
T Lymphocyte Deficiencies

DiGeorge syndrome


Partial or complete absence of T cell immunity
Chronic mucocutaneous candidiasis
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
38
Combined T- and B-Cell
Deficiencies

Severe combined immunodeficiency (SCID)






Reticular dysgenesis
• Most severe form
Adenosine deaminase (ADA) deficiency
X-linked SCID
JAK3 deficiency
IL-7 receptor deficiency
Purine nucleoside phosphorylase deficiency
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
39
Combined T and B Cell
Deficiencies





RAG-1 or RAG-2 deficiency
Bare lymphocyte deficiency
MHC class I and II deficiency
Wiskott-Aldrich syndrome
Ataxia-telangiectasia (AT)
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
40
Complement Deficiencies





C3 deficiency
Mannose-binding lectin (MBL) deficiency
Properdin deficiency
Factor I and factor H deficiency
C9 deficiency
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
41
Complement Deficiencies
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
42
Phagocytic Deficiencies

Severe congenital neutropenia





Cyclic neutropenia
Leukocyte adhesion deficiency (LAD)
C3 receptor deficiency
Chédiak-Higashi syndrome
Myeloperoxidase deficiency

Chronic granulomatous disease
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
43
Secondary Deficiencies


Also referred to as acquired deficiencies
Far more common than primary deficiencies
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
44
Secondary Deficiencies

Causes

Normal physiology conditions
 Psychologic stress
 Dietary insufficiencies
 Malignancies
 Physical trauma
 Medical treatments
 Infections
 AIDS
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
45
Graft-Versus-Host (GVH) Disease

Immunocompromised individuals are at risk for
GVH disease


T cells in the graft are mature and capable of cellmediated destruction tissues within the recipient
Not a problem if patient is immunocompetent
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
46
Evaluation of Immunity

Complete blood count (CBC) with a differential


Quantitative determination of immunoglobulins



Subpopulations of lymphocytes
Subpopulations of immunoglobulins
Assay for total complement
Skin tests
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
47
Treatment for
Immunodeficiencies




Gamma-globulin therapy
Transplantation or transfusion
Treatment with soluble immune mediators
Gene therapy
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
48